Wide Ranks

CRDL

Cardiol Therapeutics Inc.

1.58

Top Statistics
Market Cap 128 M Forward PE -4.16 Revenue Growth 0.00 %
Current Ratio 2.39 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -3.26 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 24 M Total Cash Per Share 0.3440 Total Debt 164273
Total Debt To Equity 1.07 Current Ratio 2.39 Book Value Per Share 0.4320
All Measures
Short Ratio 137.00 % Message Board Id finmb_424954803 Fax 905-481-2394
Shares Short Prior Month 710508 Return On Equity -1.08 City Oakville
Uuid ee9d962b-eed4-3063-8df9-c815990fe5d8 Previous Close 1.53 First Trade Date Epoch Utc 1 B
Book Value 0.4320 Beta 0.6970 Total Debt 164273
Volume 310289 Price To Book 3.66 Fifty Two Week Low 0.7910
Total Cash Per Share 0.3440 Shares Short Previous Month Date 1 B Target Median Price 12.22
Max Age 86400 Recommendation Mean 1.80 Sand P52 Week Change 0.3133
Target Mean Price 12.42 Net Income To Common -29337708 Short Percent Of Float 0.0106
Implied Shares Outstanding 82 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 534780 Average Volume10days 534780 Total Cash 24 M
Next Fiscal Year End 1 B Held Percent Insiders 0.0391 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 1.53
Target Low Price 11.20 Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.90
Open 1.54 Free Cashflow -11630728 State ON
Dividend Yield 0.00 % Return On Assets -0.5415 Time Zone Short Name EST
Trailing Eps -0.3800 Day Low 1.50 Address1 2265 Upper Middle Road East
Shares Outstanding 81 M Price Hint 4 Target High Price 14.05
Website https://www.cardiolrx.com 52 Week Change 0.7230 Average Volume 486601
Forward Eps -0.3100 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 224.50 % Is_sp_500 False Regular Market Day High 1.60
Profit Margins 0.00 % Debt To Equity 1.07 Fifty Two Week High 3.12
Day High 1.60 Shares Short 814793 Regular Market Open 1.54
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0102 Operating Cashflow -21577782 Currency USD
Time Zone Full Name America/New_York Market Cap 128 M Is_nasdaq_100 False
Zip L6H 0G5 Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic
Long Name Cardiol Therapeutics Inc. Regular Market Day Low 1.50 Held Percent Institutions 0.0951
Current Price 1.58 Address2 Suite 602 Enterprise To Ebitda -3.26
Financial Currency CAD Current Ratio 2.39 Industry Disp Drug Manufacturers - Specialty & Generic
Number Of Analyst Opinions 4 Country Canada Float Shares 66 M
Two Hundred Day Average 1.97 Enterprise Value 103 M Forward PE -4.16
Regular Market Volume 310289 Ebitda -31661444 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.

The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure.

It has a license agreement with Meros.

The company was incorporated in 2017 and is headquartered in Oakville, Canada.